News & Updates

Show Multimedia Only

Dupilumab shows therapeutic potential in eosinophilic gastritis

15 Jul 2026

In the treatment of patients with eosinophilic gastritis, the use of dupilumab helps improve histological outcomes, according to the proof-of-concept, phase II DEGAS study.

Dupilumab shows therapeutic potential in eosinophilic gastritis

15 Jul 2026

Contraceptive progestogens carry meningioma risk

14 Jul 2026

Progestogens used for contraception contribute to an increased risk of meningioma, as shown in a nested case-control study.

Contraceptive progestogens carry meningioma risk

14 Jul 2026

Patients with MASLD face heightened diabetes risk

14 Jul 2026 by

Metabolic dysfunction-associated steatotic liver disease (MASLD) carries an increased risk of type 2 diabetes (T2D), with the risk increase disproportionately higher for individuals with earlier-onset MASLD, as shown in a study.

Patients with MASLD face heightened diabetes risk

14 Jul 2026

Eating low-sweet snacks, caregiver education reduce children’s sugar intake

14 Jul 2026

Offering low-sweet snacks and caregiver education can help reduce daily added sugar and sugar-sweetened beverage (SSB) intakes among children and their caregivers, according to a study.

Eating low-sweet snacks, caregiver education reduce children’s sugar intake

14 Jul 2026

AI-supported digital microscopy improves lab diagnostics in primary healthcare

14 Jul 2026 by

Digital microscopy combined with artificial intelligence (AI) demonstrates comparable accuracy to the reference standard for identifying multiple targets in primary healthcare laboratories and may even increase sensitivity in diagnosis, reports a study.

AI-supported digital microscopy improves lab diagnostics in primary healthcare

14 Jul 2026

Calcium-enriched permeate supplement prevents bone loss in postmenopausal women

14 Jul 2026

Daily intake of calcium-enriched permeate (CP) supplement in two doses is comparably effective as taking calcium carbonate (CC) in suppressing bone turnover markers and maintaining bone mineral density (BMD) in postmenopausal women with vitamin D sufficiency, reveals a study, noting that inulin offers no additional advantage.

Calcium-enriched permeate supplement prevents bone loss in postmenopausal women

14 Jul 2026

Is whole goat milk formula protective against AD in infants?

14 Jul 2026 by

Results from the GIraFFE* study shed light on the potential protective effect of whole goat milk formula (WGF) against the development of atopic dermatitis (AD) in infants, compared with cow milk formula (CF).

Is whole goat milk formula protective against AD in infants?

14 Jul 2026

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

14 Jul 2026

Treatment with the combination of cagrilintide plus semaglutide is safe and efficacious for lowering glycaemic levels in individuals with early-stage type 2 diabetes inadequately controlled with diet and exercise, as shown in the phase IIIa REIMAGINE 1 trial.

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

14 Jul 2026

Tackling the increasing threat of MBL-producing pathogens and S. maltophilia: Key insights from ESCMID Global 2026

14 Jul 2026

Antimicrobial resistance (AMR) continues to challenge healthcare systems worldwide, with carbapenem-resistant Gram-negative infections among the most urgent clinical threats. At a symposium held during ESCMID Global 2026, Dr Subramanian Swaminathan (India), Dr Paula Ramírez (Spain), Prof Gian Maria Rossolini (Italy), Prof Garyfallia Poulakou (Greece), and Prof Michele Bartoletti (Italy) explored the epidemiology, diagnosis, and management of infections caused by metallo-β-lactamase (MBL)-producing organisms, with a particular focus on carbapenem-resistant Enterobacterales (CRE) and Stenotrophomonas maltophilia.

Tackling the increasing threat of MBL-producing pathogens and S. maltophilia: Key insights from ESCMID Global 2026

14 Jul 2026

Nipocalimab shows rapid, durable Hgb improvement in adults with wAIHA

14 Jul 2026 by

Treatment with nipocalimab significantly improves haemoglobin (Hgb) levels as early as week 1, with effects persisting through week 24 in patients with warm autoimmune haemolytic anaemia (wAIHA), according to the phase II/III ENERGY trial presented at EHA 2026.

Nipocalimab shows rapid, durable Hgb improvement in adults with wAIHA

14 Jul 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Dupilumab shows therapeutic potential in eosinophilic gastritis

Dupilumab shows therapeutic potential in eosinophilic gastritis

Contraceptive progestogens carry meningioma risk

Contraceptive progestogens carry meningioma risk

Patients with MASLD face heightened diabetes risk

Patients with MASLD face heightened diabetes risk

Eating low-sweet snacks, caregiver education reduce children’s sugar intake

Eating low-sweet snacks, caregiver education reduce children’s sugar intake

AI-supported digital microscopy improves lab diagnostics in primary healthcare

AI-supported digital microscopy improves lab diagnostics in primary healthcare

Calcium-enriched permeate supplement prevents bone loss in postmenopausal women

Calcium-enriched permeate supplement prevents bone loss in postmenopausal women

Is whole goat milk formula protective against AD in infants?

Is whole goat milk formula protective against AD in infants?

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

Tackling the increasing threat of MBL-producing pathogens and S. maltophilia: Key insights from ESCMID Global 2026

Tackling the increasing threat of MBL-producing pathogens and S. maltophilia: Key insights from ESCMID Global 2026

Nipocalimab shows rapid, durable Hgb improvement in adults with wAIHA

Nipocalimab shows rapid, durable Hgb improvement in adults with wAIHA